{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T18:09:10Z","timestamp":1790791750670,"version":"4.1.0"},"reference-count":34,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2017,6,20]],"date-time":"2017-06-20T00:00:00Z","timestamp":1497916800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"the Ministry of Health, Labour and Welfare of Japan and JSPS KAKENHI Grant-in-Aid for Scientific Research (C)","award":["26460174"],"award-info":[{"award-number":["26460174"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0175406","type":"journal-article","created":{"date-parts":[[2017,6,20]],"date-time":"2017-06-20T17:24:28Z","timestamp":1497979468000},"page":"e0175406","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":82,"title":["Fructo-oligosaccharides and intestinal barrier function in a methionine\u2013choline-deficient mouse model of nonalcoholic steatohepatitis"],"prefix":"10.1371","volume":"12","author":[{"given":"Kotaro","family":"Matsumoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayuko","family":"Ichimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Tsuneyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Moritoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromichi","family":"Tsunashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuhisa","family":"Omagari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masumi","family":"Hara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichiro","family":"Yasuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Miyakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Kikuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,6,20]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/jgh.12271","article-title":"Characteristics and diagnosis of NAFLD\/NASH","volume":"28","author":"E Hashimoto","year":"2013","journal-title":"J Gastroenterol Hepatol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S0025-6196(24)00530-5","article-title":"Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease","volume":"55","author":"J Ludwig","year":"1980","journal-title":"Mayo Clin Proc"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.hepres.2005.09.007","article-title":"The characteristics and natural history of Japanese patients with nonalcoholic fatty liver disease","volume":"33","author":"E Hashimoto","year":"2005","journal-title":"Hepatol Res"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1159\/000332975","article-title":"Gut microbiota and its pathophysiology in disease paradigms","volume":"29","author":"D Festi","year":"2011","journal-title":"Dig Dis"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1017\/S0007114512005235","article-title":"Linking the gut microbiota to human health","volume":"109","author":"V Robles Alonso","year":"2013","journal-title":"Br J Nutr"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"e62885","DOI":"10.1371\/journal.pone.0062885","article-title":"Molecular characterization of the fecal microbiota in patients with nonalcoholic steatohepatitis--a longitudinal study","volume":"8","author":"VW Wong","year":"2013","journal-title":"PLoS One"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1136\/gut.48.2.206","article-title":"The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor \u03b1 in the pathogenesis of non-alcoholic steatohepatitis","volume":"48","author":"AJ Wigg","year":"2001","journal-title":"Gut"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1002\/hep.22848","article-title":"Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease","volume":"49","author":"L Miele","year":"2009","journal-title":"Hepatology"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.nut.2004.12.004","article-title":"Short-chain fatty acids alter tight junction permeability in intestinal monolayer cells via lipoxygenase activation","volume":"21","author":"A Ohata","year":"2005","journal-title":"Nutrition"},{"key":"ref10","first-page":"287348","article-title":"Role of Gut barrier function in the pathogenesis of nonalcoholic fatty liver disease","volume":"2015","author":"X Dai","year":"2015","journal-title":"Gastroenterol Res Pract"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1053\/j.gastro.2012.01.034","article-title":"A high-fat diet is associated with endotoxemia that originates from the gut","volume":"142","author":"S Pendyala","year":"2012","journal-title":"Gastroenterology"},{"key":"ref12","first-page":"560620","article-title":"Fructose induced endotoxemia in pediatric nonalcoholic Fatty liver disease","volume":"2014","author":"R Jin","year":"2014","journal-title":"Int J Hepatol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.cmet.2012.05.012","article-title":"Hyperresponsivity to low-dose endotoxin during progression to nonalcoholic steatohepatitis is regulated by leptin-mediated signaling","volume":"16","author":"K Imajo","year":"2012","journal-title":"Cell Metab"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/978-1-4684-5784-1_10","article-title":"The effects of undigestible fructooligosaccharides on intestinal microflora and various physiological functions on human health","volume":"270","author":"H Hidaka","year":"1990","journal-title":"Adv Exp Med Biol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1093\/jn\/125.6.1401","article-title":"Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics","volume":"125","author":"GR Gibson","year":"1995","journal-title":"J Nutr"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"DE Kleiner","year":"2005","journal-title":"Hepatology"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1128\/AEM.69.2.1251-1262.2003","article-title":"Application of new primer-enzyme combinations to terminal restriction fragment length polymorphism profiling of bacterial populations in human feces","volume":"69","author":"K Nagashima","year":"2003","journal-title":"Appl Environ Microbiol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1002\/hep.26732","article-title":"Role of adipose triglyceride lipase (PNPLA2) in protection from hepatic inflammation in mouse models of steatohepatitis and endotoxemia","volume":"59","author":"P Jha","year":"2014","journal-title":"Hepatology"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1194\/jlr.M800042-JLR200","article-title":"Mechanisms of hepatic steatosis in mice fed a lipogenic methionine choline-deficient diet","volume":"49","author":"ME Rinella","year":"2008","journal-title":"J Lipid Res"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1111\/j.1440-1746.2008.05543.x","article-title":"Animal models of NASH: getting both pathology and metabolic context right","volume":"23","author":"CZ Larter","year":"2008","journal-title":"J Gastroenterol Hepatol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/hep.26319","article-title":"Intestinal microbiota in patients with nonalcoholic fatty liver disease","volume":"58","author":"M Mouzaki","year":"2013","journal-title":"Hepatology"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/hep.26093","article-title":"Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: a connection between endogenous alcohol and NASH","volume":"57","author":"L Zhu","year":"2013","journal-title":"Hepatology"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"G911","DOI":"10.1152\/ajpgi.00225.2013","article-title":"<italic>Lactobacillus casei<\/italic> strain Shirota protects against nonalcoholic steatohepatitis development in a rodent model","volume":"305","author":"H Okubo","year":"2013","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1093\/jn\/127.1.130","article-title":"Selected indigestible oligosaccharides affect large bowel mass, cecal and fecal short-chain fatty acids, pH and microflora in rats","volume":"127","author":"JM Campbell","year":"1997","journal-title":"J Nutr"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1365-2249.2004.02487.x","article-title":"Dietary fructooligosaccharides up-regulate immunoglobulin A response and polymeric immunoglobulin receptor expression in intestines of infant mice","volume":"137","author":"Y Nakamura","year":"2004","journal-title":"Clin Exp Immunol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"3704","DOI":"10.1038\/ncomms4704","article-title":"Generation of colonic IgA-secreting cells in the caecal patch","volume":"5","author":"K Masahata","year":"2014","journal-title":"Nat Commun"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/mnfr.201200364","article-title":"Prebiotic approach alleviates hepatic steatosis: Implication of fatty acid oxidative and cholesterol synthesis pathways","volume":"57","author":"BD Pachikian","year":"2013","journal-title":"Mol Nutr Food Res"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"e59581","DOI":"10.1371\/journal.pone.0059581","article-title":"Dietary fat content and fiber type modulate hind gut microbial community and metabolic markers in the pig","volume":"8","author":"H Yan","year":"2013","journal-title":"PLoS One"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1038\/ncomms2852","article-title":"The gut microbiota suppresses insulin-mediated fat accumulation via the short-chain fatty acid receptor GPR43","volume":"4","author":"I Kimura","year":"2013","journal-title":"Nat Commun"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"364","DOI":"10.2337\/db11-1019","article-title":"Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2","volume":"61","author":"G Tolhurst","year":"2012","journal-title":"Diabetes"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1056\/NEJMoa1205037","article-title":"Duodenal infusion of donor feces for recurrent <italic>Clostridium difficile<\/italic>","volume":"368","author":"E van Nood","year":"2013","journal-title":"N Engl J Med"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1053\/j.gastro.2013.08.058","article-title":"Therapeutic potential of fecal microbiota transplantation","volume":"145","author":"LP Smits","year":"2013","journal-title":"Gastroenterology"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1002\/hep.22711","article-title":"VSL#3 probiotic treatment attenuates fibrosis without changes in steatohepatitis in a diet-induced nonalcoholic steatohepatitis model in mice","volume":"49","author":"A Velayudham","year":"2009","journal-title":"Hepatology"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"e63388","DOI":"10.1371\/journal.pone.0063388","article-title":"Butyrate-producing probiotics reduce nonalcoholic fatty liver disease progression in rats: new insight into the probiotics for the gut-liver axis","volume":"8","author":"H Endo","year":"2013","journal-title":"PLoS One"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0175406","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T20:36:32Z","timestamp":1750365392000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0175406"}},"subtitle":[],"editor":[{"given":"Pavel","family":"Strnad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,6,20]]},"references-count":34,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2017,6,20]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0175406","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,20]]}}}